11th -13th September | Amsterdam

Main Conference Day 1

9:00 am - 9:15 am Chairman's Welcome & Icebreaker

9:15 am - 9:55 am Towards Models of Prospective Curation in the Drug Research Industry

Samiul Hasan - Director Data Curation GSK
  • Discuss drug industry data management - knowledge persistence and knowledge vigilance
  • Apply ontologies and machine learning-based approaches to deliver a much needed change
  • Improve your software design approaches in order to make the process of data and knowledge acquisition more attractive and empower scientists to do more
img

Samiul Hasan

Director Data Curation
GSK

  • Learn how to integrate machine learning into your data strategy
  • Empower your research with machine learning technologies
  • Take action from insight
img

Brunhilde Schölzke

Associate Director R&D IT
MSD Animal Health Innovation

Pavel Vacha

Associate Director, Data Science IT Hub
MSD IT Innovation

10:40 am - 11:10 am Networking Coffee Break

11:10 am - 11:50 am Data Intelligence in Pharma R&D: Semantics meets Analytics

Giovanni Tummarello - CPO/Founder Siren Solutions
  • Discover why, in complex scenarios, information is much more a “knowledge graph” than just a bunch of tables
  • Learn how data intelligence is coming together of “Semantics” (Ontologies) and analytics
  • Understand how with semantic underpinning, the investigative analytic UI can automatically suggest connections in dashboards and graph/link analysis 
img

Giovanni Tummarello

CPO/Founder
Siren Solutions

11:50 am - 12:30 pm Data Quality-Defined Analytics Processes for Drug Development

Julian Morris - Technical Director CPACT
  • Define your unique process and analytical variability quality challenges
  • Advance your predictive modelling with lessons learned from the Centre for Process Analytics & Control Technology
  • Discuss strategies to improve your data visualisation
img

Julian Morris

Technical Director
CPACT

12:30 pm - 1:30 pm Networking Lunch Break

  • Ensure authenticity of health records and protocols on record sharing
  • Eradicate fraudulent altering or modification of patient data and clinical trial data
  • Empower research and accelerating collaboration across the board in order to ensure adoption
img

Pascal Bouquet

Global Head Technology and Architecture for Global Drug Development
Novartis

2:10 pm - 2:50 pm CASE STUDY: Applied A.I. in Clinical Development

Leonardo Rodrigues - Senior Director, AI & Machine Learning BERG Heath
  • Analyse why AI should be implemented in clinical development
  • Discover the key obstacles to deploy a production-level AI in drug discovery
  • Examine examples of successful AI applications in drug discovery and patient stratification
img

Leonardo Rodrigues

Senior Director, AI & Machine Learning
BERG Heath

2:50 pm - 3:20 pm Networking Coffee Break

3:20 pm - 4:00 pm Toward a Company Wide Data Infrastructure

Maman Khaled - European HTA and Health Economics manager Otsuka Pharmaceutical Companies
  • Foster a productive culture of collaboration across departments
  • Develop your own non-competitive way to stay ahead of the curve
  • Implement a data strategy that factors in contractor obligations and market access
img

Maman Khaled

European HTA and Health Economics manager
Otsuka Pharmaceutical Companies

  • What is the best strategy to begin integrating M.L., A.I. & Blockhain into you company
  • Is it only R&D – opening and learning from collaboration externally and internally
  • Where is the proof - ROI or buzz words? 
img

Pascal Bouquet

Global Head Technology and Architecture for Global Drug Development
Novartis

img

David Whewell

Director of Architecture and Software Innovation
Merck Group

img

Brunhilde Schölzke

Associate Director R&D IT
MSD Animal Health Innovation

Wolfgang Paul

Senior Scientist, Digitalisation
Roche Diagnostics

5:00 pm - 5:30 pm Chairman's Closing Remarks